Prerequisites for phase i and phase Ii clinical trials of drugs
Jaillon, P.; Dupuis, B.
Archives des Maladies du Coeur et des Vaisseaux 82(10): 1773-1776
1989
ISSN/ISBN: 0003-9683 PMID: 2512881 Document Number: 341685
Document emailed within 1 workday
Related Documents
Jaoko, W.G.; Ogutu, H.; Wakasiaka, S.; Malogo, R.; Ndambuki, R.; Nyange, J.; Omosa-Manyonyi, G.; Fast, P.; Schmidt, C.; Verlinde, C.; Smith, C.; Bhatt, K.M.; Ndinya-Achola, J.; Anzala, O. 2009: Pregnancy rates among female participants in phase i and phase IIA AIDS vaccine clinical trials in Kenya East African Medical Journal 86(9): 430-434Plat, F. 1992: Methodology of phase Ii clinical trials of hypocholesteremic drugs: which criteria? Archives des Maladies du Coeur et des Vaisseaux 85(Special Issue 2): 117-120
Teehan, M. 1994: Guidelines for phase IV clinical trials. Joint Committee on Phase IV Clinical Trial Guidelines Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 39(10): 629-633
Davis, T.; Schoenfeldt, M. 2004: Clinical trials referral resource. Current phase IIi clinical trials for adults with leukemia or lymphoma Oncology 18(1): 62; 65, 69
Cheson, B.D.; Phillips, P.H.; Trimble, E. 1994: Clinical trials. Referral resource. Phase Ii Ovarian Cancer Trials Oncology 8(4): 73-74
Trimble, E.L.; Schoenfeldt, M. 2004: Clinical trials referral source. Current randomized phase IIi trials in gynecologic cancer Oncology 18(13): 1642; 1645-1646
Durry, G.; Dion, S. 1986: The ethical approach to phase I clinical trials in oncology Drugs under Experimental and Clinical Research 12(1-2): 21-22
Saw, S.M.; Lim, S.G. 2000: Clinical drug trials: practical problems of phase III Annals of the Academy of Medicine Singapore 29(5): 598-605
Jakab, G.áb. 2012: Assessment of the clinical and MRi results of the FREEDOMS and TRANSFORMS phase III. clinical trials Ideggyogyaszati Szemle 65(5-6): 207-208
Xie, Y.; Wang, Y.; Tian, F.; Wang, Y. 2011: Basic requirements on post-marketing clinical re-evaluation of chinese medicine and phase IV clinical trials Zhongguo Zhong Yao Za Zhi 36(20): 2764-2767
Frimmelová, M.; Toman, R.; Pompach, P.; Škultéty, L. 2016: Modifications in the glycerophospholipid composition between the Coxiella burnetii phase I and phase II cells suggest an association with phase variation of the bacterium Acta Virologica 60(1): 27-33
Muggia, F.M.; Rozencweig, M.; Chiuten, D.F.; Jensen-Akula, M.S.; Charles, L.M.; Kubota, T.T.; Bono, V.H. 1980: Phase Ii trials: use of a clinical tumor panel and overview of current resources and studies Cancer Treatment Reports 64(1): 1-9
Hou, M-Mo.; Liu, X.; Wheler, J.; Naing, A.; Hong, D.; Bodurka, D.; Schmeler, K.; Tsimberidou, A.; Janku, F.; Zinner, R.; Piha-Paul, S.; Hu, C-Yuan.; Lu, K.; Kurzrock, R.; Fu, S. 2014: Outcomes of patients with metastatic cervical cancer in a phase I clinical trials program Anticancer Research 34(5): 2349-2355
Becouarn, Y.; Rougier, P. 1998: Clinical efficacy of oxaliplatin monotherapy: phase Ii trials in advanced colorectal cancer Seminars in Oncology 25(2 Suppl 5: 23-31
Dhall, K.; Dogra, M. 1988: Phase i and Ii clinical trials with Vicoa Indica (Banjauri), a herbal medicine, as an antifertility agent Contraception 37(1): 75-84
Von Eickstedt, K.W. 1973: Experience with phase i of clinical pharmacology in the registration of drugs Arzneimittel-Forschung 23(11 Suppl): 1677-1678
Lutfullin, A.; Kuhlmann, J.; Wensing, G. 2005: Adverse events in volunteers participating in phase I clinical trials: a single-center five-year survey in 1,559 subjects International Journal of Clinical Pharmacology and Therapeutics 43(5): 217-226
Thomas, J.; McEvoy, J.P.; Miller, B.J. 2019: Urinary tract infection, inflammation, and cognition in phase 1 of the Clinical Antipsychotic Trials of Intervention Effectiveness Study Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists 31(4): 242-248
Becker, C. 2004: A brand new bag. Trauma-care revolution among benefits touted as blood substitute enters critical phase of clinical trials Modern Healthcare 34(15): 30
Hebert, A.A.; Albareda, N.; Rosen, T.; Torrelo, A.; Grimalt, R.; Rosenberg, N.; Zsolt, I.; Masramon, X. 2018: Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients with Impetigo: Pooled Analysis of Phase 3 Clinical Trials Journal of Drugs in Dermatology: Jdd 17(10): 1051-1057